-

Meeting of the Board of Directors of Valerio Therapeutics S.A. on November 13, 2024

PARIS--(BUSINESS WIRE)--Regulatory News:

At its meeting of November 13, 2024, the Board of Directors of Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), (“Valerio Therapeutics” or the “Company”) decided to appoint Mr Julien Miara as CEO and Chairman of the Board of Valerio Therapeutics, succeeding Ms Shefali Argawal, effective immediately.

Future evolutions related to the Company’s governance will be announced at a later date.

Contacts

Valerio Therapeutics
Investor Relations
ir@valeriotx.com
France: +33 (0) 1 70 38 33 99
U.S.: +1 617 366 1022

Valerio Therapeutics S.A.

BOURSE:ALVIO

Release Versions

Contacts

Valerio Therapeutics
Investor Relations
ir@valeriotx.com
France: +33 (0) 1 70 38 33 99
U.S.: +1 617 366 1022

More News From Valerio Therapeutics S.A.

Valerio Therapeutics Announces the Appointment of Professor Eric Vivier as Observer to Its Board of Directors

PARIS--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics (“Valerio Therapeutics” or the “Company”) (Euronext Growth Paris: ALVIO) announces the appointment of Professor Eric Vivier as an Observer to its Board of Directors. His nomination as a Director will be submitted to shareholders at the Company’s next general meeting. Professor Eric Vivier works within Aix Marseille University and Assistance Publique-Hôpitaux de Marseille (AP-HM) and is also a professor at École Polytechnique (X). He...

Valerio Therapeutics: Postponement of 2024 Annual Financial Report Publication and the Approval of Financial Statements

PARIS--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) (the “Company”) announces the postponement of the publication of its 2024 annual financial report, initially scheduled for April 30, 2025, as well as the finalization and approval of its statutory and consolidated financial statements for 2024. The Company is facing significant difficulties in accessing the accounting records of its U.S. subsidiary, Valerio Therapeutics Inc. Although the assets rel...

VALERIO THERAPEUTICS: List of the Board Members Positions Held in Other Companies as of March 19, 2025

PARIS--(BUSINESS WIRE)--Regulatory News: VALERIO THERAPEUTICS (Paris:ALVIO):  Name of Director Other offices and functions   Julien MIARA Chief Executive Officer and Director   Managing Director at Invus Director of Sensorion Director of Versity   Jacques MALLET Director and Chairman of the Board   Chairman of Gamma-X Corporate Advisory Director of Technoflex Director of the Fournier Majoie Foundation   FINANCIERE DE LA MONTAGNE, represented by Nicolas TREBOUTA Director   Manager of SARL Financ...
Back to Newsroom